Suppression of CD300A inhibits the growth of diffuse large B-cell lymphoma

CD300A is a type I transmembrane receptor protein which has shown inhibitory effects on B-cell receptor-mediated signals. In an analysis of public dataset, we found that CD300A mRNA levels were inversely correlated with the overall survival time of patients with diffuse large B-cell lymphoma (DLBCL)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Lei, Xu, Yulian, Zeng, Xinli, Fang, Jianchen, Morse, Herbert C., Zhou, Jeff X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741597/
https://www.ncbi.nlm.nih.gov/pubmed/26435477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741597/
https://www.ncbi.nlm.nih.gov/pubmed/26435477

Ejemplares similares